利培酮与氟哌啶醇治疗老年谵妄的对照试验
2014-09-26高赫
高赫
[摘要] 目的 比较利培酮和氟哌啶醇治疗老年谵妄的疗效和安全性。 方法 将52例老年谵妄患者随机分为试验组与对照组。试验组患者每晚口服利培酮片1mg,并根据疗效和耐受性调整剂量,最大剂量4mg。对照组患者予以肌注氟哌啶醇针5~10mg。两组患者均治疗2周。采用谵妄评定量表中文版(CAM-CR)评价疗效;以药物副作用量表(TESS)比较两组患者的不良反应发生情况。 结果 治疗后,两组患者CAM-CR评分与同组治疗前比较,差异均有统计学意义(P<0.05),而两组间评分比较,差异无统计学意义(P>0.05);治疗组和对照组患者的总有效率分别为80.8%和92.3%,两组比较差异无统计学意义(P>0.05)。两组患者不良反应比较,差异无统计学意义(P>0.05)。 结论 利培酮治疗老年谵妄的疗效和安全性与氟哌啶醇相当。
[关键词] 利培酮;氟哌啶醇;谵妄;老年患者
[中图分类号] R749.4 [文献标识码] B [文章编号] 2095-0616(2014)17-53-03
[Abstract] Obiective To compare the effectiveness and safety of Risperidone and Haloperidol in the treatment of delirium in older adults. Methods 52 patients with senile delirium were randomly divided into treatment group and control group.Treatment group was given different dose of Risperidone tablet at night by therapeutic effect and tolerance;control group were treated with intramuscular injection of haloperidol at bedtime.Therapeutic efficacy and adverse drug reactions were compared after 2 weeks treatment. Results In all groups,the CAM-CR score decreased significantly over the study period(P<0.05).However,there were no significant differences in the improvement of scores among the two groups (P>0.05).For treatment group and control group,the effective rate was 80.8% and 92.3% respectively,there was no statistical significance (P>0.05).There was no significant difference in the frequency of adverse effects between 2 groups (P>0.05). Conclusion Risperidone and Haloperidol have similar effects and safety in treating senile delirium.
[Key words] Risperidone;Haloperidol;Delirium;Elderly
谵妄做为一种相对常见的脑器质性综合征,在老年住院患者中的发生率可达10%~40%[1],并与死亡率的增加存在相关[2]。谵妄的治疗主要包括原发疾病的治疗和精神药物治疗,其中氟哌啶醇应用较为广泛[3]。然而,大量、长期应用氟哌啶醇可引起锥体外系反应、Q-T间期延长以及致命性心律失常等严重不良反应,因此,非典型抗精神病药物日益受到学界关注。部分研究表明,利培酮对谵妄患者有效[4]。为证实其在老年患者中的疗效与安全性,我们应用利培酮治疗老年谵妄患者,报道如下。
1 资料与方法
1.1 一般资料
选择2012年2月~2013年12月在宁波市康宁医院确诊为谵妄的老年患者52例,采用随机数字表法将入选患者均分为试验组和对照组。试验……
